Xenon Pharmaceuticals Inc. (XENE) - Insider Holders & Insider Ownership

List of insiders holdings for Xenon Pharmaceuticals Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
1MX Associates LLP
10% Owner		2015-01-07 12:57:301,474,660
0		1,474,660Form 4
2BVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BIOTECHNOLOGY VALUE FUND II LP
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF INC
LAMPERT MARK N
10% Owner		2023-02-13 20:20:161,271,243
0		1,271,243Form 13G
3STEIN EVAN A.
Director		2017-02-13 09:17:32443,916
0		443,916Form 13G
4Kelly Thomas Patrick
Chief Financial Officer		2025-10-17 18:43:47255,000
0		255,000Form 4
5Cline Darren S
Chief Commercial Officer		2025-06-24 21:35:16185,800
0		185,800Form 4
6HOLLER FRANK A
Director		2021-06-01 16:07:31143,653
1,184		144,837Form 4
7Von Seggern Christopher
Chief Commercial Officer		2024-03-12 18:42:52100,000
0		100,000Form 4
8KENNEY CHRISTOPHER JOHN
Chief Medical Officer		2025-03-13 19:31:0195,000
0		95,000Form 4
9DiFabio Andrea
Chief Legal Officer		2025-03-13 19:30:4495,000
0		95,000Form 4
10TARNOW MICHAEL M
Director		2021-05-20 16:18:4477,942
0		77,942Form 4
11AZAB MOHAMMAD
Director		2023-12-20 17:04:2374,225
0		74,225Form 4
12ROBIN SHERRINGTON
EVP, Strategy & Innovation		2024-03-12 18:35:5965,000
0		65,000Form 4
13EMPFIELD JAMES R.
EVP, Drug Discovery		2024-03-12 18:37:2565,000
0		65,000Form 4
14AYCARDI-FONSECA ERNESTO
CMO		2020-03-13 17:06:3865,000
0		65,000Form 4
15MORTIMER IAN
PRESIDENT, CEO & INTERIM CFO		2025-10-01 19:17:1131,302
14,300		45,602Form 4
16CORRAINI KAREN G.
Gen. Counsel & Corp. Secretary		2015-03-19 20:52:2735,000
0		35,000Form 4
17GANNON STEVEN
Director		2025-06-06 17:58:5726,798
0		26,798Form 4
18PATOU GARY
Director		2025-06-06 18:00:2519,657
0		19,657Form 4
19Machado Patrick
Director		2025-06-06 18:00:1319,657
0		19,657Form 4
20Gover Justin D.
Director		2025-06-06 17:59:4819,657
0		19,657Form 4
21GAROFALO ELIZABETH A.
Director		2025-06-06 17:59:2619,657
0		19,657Form 4
22Svoronos Dawn
Director		2025-06-06 17:57:2519,657
0		19,657Form 4
23Cannon Gillian
Director		2025-06-06 17:57:5819,657
0		19,657Form 4
24PIMSTONE SIMON N.
Director		2023-06-02 17:21:1418,475
0		18,475Form 4
25SCHELLER RICHARD H
Director		2019-09-18 19:39:0915,000
0		15,000Form 4
26GOLDBERG Y. PAUL
SVP, Clinical Development		2017-10-24 18:45:3211,000
0		11,000Form 4
27Desjardins Clarissa
Director		2020-06-02 16:58:0810,000
0		10,000Form 4
28Hayden Michael R
Director		2021-06-03 21:07:4810,000
0		10,000Form 4
29COHEN CHARLES J.
VP, Biology		2018-12-13 13:56:506,550
0		6,550Form 4
30AULIN SHERRY
Chief Financial Officer		2024-12-19 18:57:426,000
0		6,000Form 4
31Bridger Gary
EVP, Research & Development		2014-11-25 21:20:385,144
0		5,144Form 4
32Evans Johnston L
Director		2015-05-06 15:46:213,086
0		3,086Form 4
33WINQUIST RAYMOND
Head, Translational Research		2017-08-21 16:48:271000
0		1000Form 4